In conclusion, our findings describe a new regulatory signaling axis, LINC01554/G3BP2/HDGF, that facilitates ESCC metastasis, and highlight that G3BP2 could be a promising therapeutic target for treatment of ESCC. Here, G3BP2 is linked to esophageal squamous cell carcinoma.